Small peptides containing phosphotyrosine and adjacent αMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain

被引:42
|
作者
Liu, WQ [1 ]
Vidal, M [1 ]
Gresh, N [1 ]
Rogues, BP [1 ]
Garbay, C [1 ]
机构
[1] UFR Sci Pharmaceut & Biol, CNRS UMR 8600, INSERM U266, Dept Pharmacochim Mol & Struct, F-75270 Paris 06, France
关键词
D O I
10.1021/jm9911074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of small peptides with the sequence mAZ-pTyr-Xaa-Asn-NH2, where Xa a de notes alpha-methylphosphotyrosine or its carboxylic mimetics, were synthesized as inhibitors of the Grb2 SH2 domain. Peptide 3 with (alpha-Me)pTyr as Xaa has the highest affinity for Grb2 (K-d = 3 +/- 1 nM) and exhibits to date the best inhibitory activity (IC50 = 11 +/- 1 nM) to displace PSpYVNVQN-Grb2 interaction in an ELISA test. The lower affinities of peptides with (a-Me)Tyr, (alpha-Me)Phe(4-CO2H), or (alpha-Me)Phe(4-CH2CO2H) as Xaa demonstrate the importance of a double charged phosphate group at the pY+1 position. Molecular modeling showed additional hydrogen bond interactions provided by the (alpha-Me)pTyr residue with the Grb2 SH2 domain. These results thus show that the effect of hydrophobic pY+1 residues, initially put forth to increased the binding affinities, can be further enhanced by a (-Me)pTyr residue which has both hydrophobic and hydrophilic properties.
引用
收藏
页码:3737 / 3741
页数:5
相关论文
共 50 条
  • [21] STRUCTURE-ACTIVITY STUDIES OF SH2 DOMAIN BINDING PEPTIDES CONTAINING O-PHOSPHOTYROSINE ANALOGS
    ROLLER, PP
    NOMIZU, M
    OTAKA, A
    SMYTH, MS
    WOLF, G
    CASE, R
    SHOELSON, SE
    BURKE, TR
    FASEB JOURNAL, 1994, 8 (07): : A1391 - A1391
  • [22] Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing α-methylphenylalanyl based phosphotyrosyl mimetics
    Oishi, S
    Karki, RG
    Kang, SU
    Wang, XZ
    Worthy, KM
    Bindu, LK
    Nicklaus, MC
    Fisher, RJ
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 764 - 772
  • [23] Novel phosphotyrosine mimetics in the design of peptide ligands for pp60(src) SH2 domain
    Shahripour, A
    Plummer, MS
    Lunney, EA
    Para, KS
    Stankovic, CJ
    Rubin, JR
    Humblet, C
    Fergus, JH
    Marks, JS
    Herrera, R
    Hubbell, SE
    Saltiel, AR
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) : 1209 - 1214
  • [24] Rational design of small peptides inhibitors of Grb2 SH2 domain in Ras signaling pathway and their prodrug as antiproliferative agents.
    Vidal, M
    Liu, WQ
    Rogues, BP
    Garbay, C
    CLINICAL CANCER RESEARCH, 2000, 6 : 4495S - 4495S
  • [25] Design and synthesis of conformationally constrained Grb2 SH2 domain inhibitors.
    Gao, Y
    Voigt, JH
    Kelley, J
    Yang, DJ
    Burke, TR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U580 - U580
  • [26] Developing phosphotyrosine- mimicking peptides for the inhibition of the STAT3 SH2 domain
    Cerulli, Robert
    Kritzer, Joshua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [27] Highly potent inhibitors of the Grb2-SH2 domain
    Schoepfer, J
    Fretz, H
    Gay, B
    Furet, P
    García-Echeverría, C
    End, N
    Caravatti, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) : 221 - 226
  • [28] Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries
    Hart, CP
    Martin, JE
    Reed, MA
    Keval, AA
    Pustelnik, MJ
    Northrop, JP
    Patel, DV
    Grove, JR
    CELLULAR SIGNALLING, 1999, 11 (06) : 453 - 464
  • [29] MEDI 527-Potent antagonists of the Grb2-SH2 domain: Not relying on phosphotyrosine mimics
    Jiang, Sheng
    Li, Peng
    Peach, Megan L.
    Fisher, Robert J.
    Nicklaus, Marc C.
    Roller, Peter P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [30] STRUCTURE OF MUTANT TEF1W OF THE SRC SH2 DOMAIN COMPLEXED WITH PHOSPHOTYROSINE CONTAINING PEPTIDES.
    Nachman, Joseph
    Kimber, Matthew
    Cunningham, Annie
    Pai, Emil
    Gish, Gerald
    Pawson, Antony
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 313 - 314